ATLAS 2030 receives CE marking for international clinical use

May 12, 2021 · Regulatory · Marsi Bionics · Exoskeleton

The CSIC presented the European certification granted to Marsi Bionics' ATLAS 2030 paediatric exoskeleton on 12 May 2021.

Marsi Bionics company media
Company media · Marsi Bionics
  • The marking enabled the device to move from robotic research into hospitals and rehabilitation clinics across the European market.
  • The certified indication covered paediatric patients with spinal muscular atrophy or cerebral palsy.
  • CSIC described the aluminium-and-titanium system as weighing 12 kilograms, with ten powered joints that support standing and walking.